Trials / Unknown
UnknownNCT01493739
EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study aims on the combinatorial results of cytology, histopathology and microbiology obatined by EBUS-TBNA for unselected mediastina lesions.
Detailed description
A number of studies have proved EBUS-TBNA to be useful for lymph node staging in lung cancer. The diagnostic performance is equivalent to mediastinoscopy while the invasiveness is far less. This study primarily focusing on merged approach of cytology, histopathology and microbioloogy obatined by EBUS-TBNA for unselected mediastina lesions.
Conditions
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2011-12-16
- Last updated
- 2011-12-16
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01493739. Inclusion in this directory is not an endorsement.